ECOR electrocore.com: Long-Term Debt to Capital Coefficient

Corporate emblem and logo of electroCore Inc (ECOR)

electroCore, Inc. (ECOR) generates revenue from the supply of non-invasive devices for the treatment of cluster headaches and migraines. The current level of long-term financial dependence reflects borrowing dynamics where the status is 0.00. Regular sales of gammaCore activation cards ensure business stability, creating a predictable cash flow. The company's growth relies on expanding distribution through US Veterans Affairs hospitals to scale profits.

ECOR - electrocore.com Long-Term Debt to Equity over the range 07/04/2022 - 10/27/2026
Brand item of electroCore Inc

Conservative capital demands absolute transparency regarding debt load to assess the issuer's financial stability. This metric measures the proportion of liabilities with a maturity exceeding one year relative to the market value of equity. A steady cash flow from the sale of medical stimulators minimizes liquidity gap risks for electroCore, Inc. (ECOR). By analyzing the long-term debt-to-equity coverage ratio, an investor can see the current impact of borrowings on the business value. The trend in the long-term debt-to-equity coverage ratio allows for the prompt adjustment of portfolio structure.

Key competitors

Long-Term Loans to Capital Ratio DexCom Inc|Penumbra Corp (PEN) - Long-Term Debt to Capital|Long-Term Debt to Capital Coefficient Novanta Photonics (NOVT)|HAE: Long-Term Debt to Capital|inspiresleep.com - Long-Term Liabilities to Capital|Long-Term Debt to Equity PROCEPT BioRobotics Corporation (PRCT)|CNMD - Long-Term Debt to Capital Coefficient|PLSE: Long-Term Debt to Capital|INMD (InMode MD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc PMI|Long-Term Liabilities to Equity surmodics.com|Eversense - Long-Term Debt to Capital|Long-Term Liabilities to Capital NeuroPace Inc NPCE|Long-Term Debt to Equity Ratio TCMD (Tactile Medical)|SNWV - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Outset Medical, Inc. OM|ELMD - Long-Term Loans to Capital Ratio|LENSAR - Long-Term Debt to Capital|AVITA Medical Inc. (RCEL) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital PROF|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|EDAP TMS S.A. (EDAP) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient APYX (apyxmedical.com)|IceCure Medical - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Pulmonx Corp LUNG|TELA (TELA Bio Corp) - Long-Term Debt to Capital|CTSO - Long-Term Liabilities to Capital|Long-Term Debt to Capital Sensus Healthcare, Inc.|zynex.com (ZYXI) - Long-Term Debt to Capital Ratio|RBOT: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Inspira Technologies Oxy B.H.N. Ltd|Long-Term Debt to Capital ICU (SeaStar Medical Holding Corp)|Long-Term Debt to Equity Ratio iridex.com (IRIX)|Long-Term Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Beyond Air Inc - Long-Term Debt to Capital|PFSA - Long-Term Debt to Equity|STRATA Skin Sciences (SSKN) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio GlucoTrack GCTK|NanoVibronix Inc. (NAOV) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital VERO (Venus Concept Inc.)|Long-Term Liabilities to Capital NUWE|AEMD: Long-Term Debt to Equity|Long-Term Indebtedness to Equity asensus.com ASXC|Long-Term Debt to Equity Ratio AVGR (Avinger, Inc)|Long-Term Debt to Capital BioSig Technologies Inc. BSGM|Long-Term Debt to Capital CUTR (Cutera, Inc.)|KNW: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Inari Medical (NARI)|NVRO (Nevro Corp) - Long-Term Liabilities to Equity|Long-Term Debt to Equity RSLS|Long-Term Debt to Equity Ratio Silk Road Medical Inc